<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00870597</url>
  </required_header>
  <id_info>
    <org_study_id>HOB-03</org_study_id>
    <nct_id>NCT00870597</nct_id>
  </id_info>
  <brief_title>Transconjunctival Sutureless 25-Gauge Vitrectomy</brief_title>
  <acronym>TSV-25G</acronym>
  <official_title>Transconjunctival Sutureless 25-Gauge Vitrectomy for Visually Significant Vitreous Floaters in Patients With Multifocal Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Oftalmologico de Brasilia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Oftalmologico de Brasilia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless
      vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal
      intraocular lens (IOL) implantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose: The aim of this study was to evaluate the role of 25-gauge transconjuntival
      sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent
      multifocal intraocular lens (IOL) implantation.

      Setting: Hospital Oftalmológico de Brasília, Brasília, DF, Brazil.

      Methods: Fourteen eyes of 11 patients with multifocal IOL implant associated with vitreous
      opacities that underwent 25-gauge vitrectomy were prospectively analyzed. Information
      collected included near and distance uncorrected visual acuity (UCDVA), best corrected
      distance visual acuity (BCDVA), and the spherical equivalent (SE) before and 3 months after
      vitrectomy. Patients were questioned about surgery satisfaction and visual improvement after
      vitrectomy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Visual Acuity</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multifocal IOL implantation without transconjunctival vitrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Multifocal IOL implantation + Vitrectomy</intervention_name>
    <description>25-gauge transconjuntival sutureless vitrectomy (TSV)</description>
    <arm_group_label>1</arm_group_label>
    <other_name>VITRECTOMY</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Multifocal IOL implantation - Vitrectomy</intervention_name>
    <description>Multifocal IOL implantation without transconjunctival vitrectomy</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  disabling vitreous floaters

          -  Age-related cataract Unsatisfactory correction with glasses

        Exclusion Criteria:

          -  central endothelial cell count less than 2000 cells/mm2

          -  glaucoma or intraocular pressure greater than 21 mmHg

          -  amblyopia

          -  retinal abnormalities

          -  diabetes mellitus

          -  steroid or immunosuppressive treatment

          -  connective tissue diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>PATRICK TZELIKIS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Oftalmologico de Brasilia</name>
      <address>
        <city>Brasília</city>
        <state>DF</state>
        <zip>70000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2009</study_first_submitted>
  <study_first_submitted_qc>March 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2009</study_first_posted>
  <last_update_submitted>March 26, 2009</last_update_submitted>
  <last_update_submitted_qc>March 26, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 27, 2009</last_update_posted>
  <responsible_party>
    <name_title>PATRICK TZELIKIS</name_title>
    <organization>UNIVERSIDADE FEDERAL DE MINAS GERAIS</organization>
  </responsible_party>
  <keyword>Floaters</keyword>
  <keyword>multifocal IOL</keyword>
  <keyword>visual complaints</keyword>
  <keyword>vitrectomy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

